Advertisement
Australia markets closed
  • ALL ORDS

    7,817.40
    -81.50 (-1.03%)
     
  • ASX 200

    7,567.30
    -74.80 (-0.98%)
     
  • AUD/USD

    0.6412
    -0.0014 (-0.21%)
     
  • OIL

    82.35
    -0.38 (-0.46%)
     
  • GOLD

    2,391.70
    -6.30 (-0.26%)
     
  • Bitcoin AUD

    101,446.54
    +3,698.48 (+3.78%)
     
  • CMC Crypto 200

    1,337.88
    +25.25 (+1.96%)
     
  • AUD/EUR

    0.6015
    -0.0016 (-0.26%)
     
  • AUD/NZD

    1.0891
    +0.0017 (+0.15%)
     
  • NZX 50

    11,796.21
    -39.83 (-0.34%)
     
  • NASDAQ

    17,394.31
    -99.31 (-0.57%)
     
  • FTSE

    7,835.50
    -41.55 (-0.53%)
     
  • Dow Jones

    37,775.38
    +22.07 (+0.06%)
     
  • DAX

    17,718.42
    -118.98 (-0.67%)
     
  • Hang Seng

    16,224.14
    -161.73 (-0.99%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

3 Reasons to Buy Canopy Growth Instead of Aurora Cannabis

3 Reasons to Buy Canopy Growth Instead of Aurora Cannabis

Year to date, shares of the two largest companies in the cannabis sector, Canopy Growth (NYSE: CGC) and Aurora Cannabis (NYSE: ACB), have not been performing well. Since the beginning of the year, Canopy Growth stock has declined by more than 20%, while Aurora's stock has fallen by as much as 50%. In fiscal year 2020, Canopy Growth generated more than $399 million in net revenue, representing a growth of 76% compared with last year.